Cancer diagnostics News and Research

RSS

Innovative method to map specific DNA markings could be used for early cancer detection

Researchers from the Perelman School of Medicine at the University of Pennsylvania have invented a new way to map specific DNA markings called 5-methylcytosine (5mC) which regulate gene expression and have key roles in health and disease.

15 Jun 2023

How the COVID pandemic has improved genomics

In this interview, Davide Cacchiarelli, Molecular Biology and Genomics Professor at the University of Naples talks to NewsMed about how the COVID pandemic has highlighted the vital role of genomic surveillance and improved genomics.

From MGI 4 May 2023

New AI-based method for virtual staining of histopathological tissue samples

Researchers from the University of Eastern Finland, the University of Turku, and Tampere University have developed an artificial intelligence-based method for virtual staining of histopathological tissue samples as a part of the Nordic ABCAP consortium. Chemical staining has been the cornerstone of studying histopathology for more than a century and is widely applied in, for example, cancer diagnostics.

18 Apr 2023

Light-based technology could improve cancer diagnostics

Machines are currently learning how to identify cancer cells with the help of manipulated light. This approach may help to take the pressure off our hard-pressed health services and reduce waiting times for anxious patients.

14 Feb 2023

Integrating AI with infrared imaging to improve colon cancer diagnosis

Artificial intelligence and infrared imaging automatically classify tumors and are faster than previous methods.

14 Feb 2023

Study details the “immunometabolic editing” mechanism of tumor evolution

A Ludwig Cancer Research study has discovered that the immune system's surveillance of cancer can itself induce metabolic adaptations in the cells of early-stage tumors that simultaneously promote their growth and equip them to suppress lethal immune responses.

5 Jan 2023

Cell-based method can predict how breast cancer patients will respond to treatments

Researchers at Karolinska Institutet in Sweden have developed a method that should be able to predict whether a patient with breast cancer will benefit from a particular treatment or not.

27 Dec 2022

Study reveals mechanism by which malignant cells shut down anti-cancer immune responses

A Ludwig Cancer Research study has revealed a single protein expressed at high levels by cancer cells across a broad range of malignancies that erects a multifaceted barrier to anti-cancer immune responses in mouse models of cancer and so shields tumors from immune detection and destruction.

20 Nov 2022

MGI announces European launch of new MGISP-Smart 8 automated sample preparation system and empowerment program at MEDICA to further access to genomics

MGI, a company committed to building core tools and technology to lead life science, today announced the introduction of the latest MGISP-Smart 8 automated sample preparation system to Europe and the first iteration of its Empowerment Program at the MEDICA Trade Fair, taking place November 14-17 in Düsseldorf.

From MGI 17 Nov 2022

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse models of multiple cancers.

28 Oct 2022

Study develops a strategy to noninvasively track tumor-associated macrophages

A Ludwig Cancer Research study has developed a strategy to noninvasively track immune cells known as macrophages within brain and breast tumors in living mice.

19 Oct 2022

Electronic nose can distinguish between people with and without lung cancer

Is it possible to detect lung cancer by smelling the air that someone exhales? Sharina Kort, lung specialist in training at MST, recently earned a PhD from the University of Twente based on her research into that topic.

18 Oct 2022

New partnership creates an automated anatomic pathology slide-scanning solution

Sakura Finetek, a global leader in histopathology products and Evident Scientific, a wholly owned subsidiary of Olympus Corporation, and a global leader in microscopy and imaging solutions, today announced a collaboration to offer a full workflow solution for anatomic pathology slide preparation and high-resolution digital scanning in the Americas.

From Evident Corporation - Life Sciences 13 Oct 2022

Combination of three existing drugs extends survival in mouse models of lethal brain cancer

A Ludwig Cancer Research study has identified a combination of three existing drugs that significantly extends survival in mouse models of the lethal brain cancer glioblastoma multiforme (GBM).

20 Sep 2022

Study finds significant difference in the gut microbiota of men with prostate cancer

Researchers have found a significant difference in the gut microbiota of men with prostate cancer, compared with those who have benign biopsies.

1 Jul 2022

Deep visual proteomics is redefining cancer diagnostics

In a recent study published in the journal Nature Biotechnology, researchers introduced deep visual proteomics (DVP), an amalgamation of artificial intelligence (AI) for image analysis and mass spectrometry (MS) for proteomic profiling of biological samples.

22 May 2022

Cancer diagnostics News and Research

Innovative method to map specific DNA markings could be used for early cancer detection

How the COVID pandemic has improved genomics

New AI-based method for virtual staining of histopathological tissue samples

Light-based technology could improve cancer diagnostics

Integrating AI with infrared imaging to improve colon cancer diagnosis

Study details the “immunometabolic editing” mechanism of tumor evolution

Cell-based method can predict how breast cancer patients will respond to treatments

Study reveals mechanism by which malignant cells shut down anti-cancer immune responses

MGI announces European launch of new MGISP-Smart 8 automated sample preparation system and empowerment program at MEDICA to further access to genomics

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

Study develops a strategy to noninvasively track tumor-associated macrophages

Electronic nose can distinguish between people with and without lung cancer

New partnership creates an automated anatomic pathology slide-scanning solution

Combination of three existing drugs extends survival in mouse models of lethal brain cancer

Study finds significant difference in the gut microbiota of men with prostate cancer

Deep visual proteomics is redefining cancer diagnostics

Study modeling tumor evolution reveals a central tradeoff that could be exploited for cancer treatment

Cancer mortality in sub-Saharan Africa could reach 1 million by 2030 without rapid interventions

Low-cost handheld device could cut the rate of unnecessary skin biopsies

Lateral flow assays: The possibilities beyond COVID-19

Cancer Research eBook

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News